2017年拉斯克奖

doi:10.3969/j.issn.1006-7795.2017.05.028

首都医科大学学报 ›› 2017, Vol. 38 ›› Issue (5): 777-781.doi: 10.3969/j.issn.1006-7795.2017.05.028

2017年拉斯克奖

巫剑红¹, 卢丹¹, 张婷², 代荫梅¹, 王晓民²

1. 首都医科大学附属北京妇产医院妇科, 北京 100026;
2. 首都医科大学基础医学院神经生物学系, 北京 100069

收稿日期:2017-09-24 出版日期:2017-09-21 发布日期:2017-10-18
通讯作者: 代荫梅, 王晓民 E-mail:fcyydym@163.com;xmwang@ccmu.edu.cn

The 2017 Lasker Awards

Wu Jianhong¹, Lu Dan¹, Zhang Ting², Dai Yinmei¹, Wang Xiaomin²

1. Department of Gynecology, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing 100026, China;
2. Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China

Received:2017-09-24 Online:2017-09-21 Published:2017-10-18

摘要/Abstract

摘要： 北京时间2017年9月6日，拉斯克奖获奖者名单公布。基础医学奖授予瑞士巴塞尔大学的Michael N.Hall教授，以表彰他发现了营养活化的西罗莫司靶蛋白（target of rapamycin，TOR）及其在细胞生长代谢调控中的关键作用。临床医学研究奖授予美国国立癌症研究所的Douglas R.Lowy教授和John T.Schiller教授，以表彰他们为预防宫颈癌及其他肿瘤而开发的人乳头瘤病毒（human papillomavirus， HPV）疫苗所带来的技术进步。公共服务奖授予美国计划生育联合会，以表彰该机构在过去超过一个世纪的时间里为数百万妇女提供必需的健康服务和生殖保健服务。

关键词: 拉斯克奖, TOR蛋白, HPV疫苗, 计划生育

Abstract: In September 6, 2017, the list of winners of the year's Lasker Awards were released. The Albert Lasker Basic Medical Research Award honors Michael N. Hall from University of Basel, Switzerland, for his discovery of the nutrient-activated target of rapamycin (TOR) proteins and their central role in the metabolic control of cell growth. The Lasker~DeBakey Clinical Medical Research Award honors Douglas R. Lowy and John T. Schiller from the National Cancer Institute, whose technological advances enabled the development of human papillomavirus (HPV) vaccines, which prevent cervical cancer and other tumors. The 2017 Lasker~Bloomberg Public Service Award honors Planned Parenthood for providing essential health services and reproductive care to millions of women for more than a century.

Key words: Lasker Awards, TOR protein, human papillomavirus (HPV) vaccines, reproductive care

巫剑红, 卢丹, 张婷, 代荫梅, 王晓民. 2017年拉斯克奖[J]. 首都医科大学学报, 2017, 38(5): 777-781.

Wu Jianhong, Lu Dan, Zhang Ting, Dai Yinmei, Wang Xiaomin. The 2017 Lasker Awards[J]. Journal of Capital Medical University, 2017, 38(5): 777-781.

参考文献

[1] Evelyn Strauss. The 2017 LASKER AWARDS[EB/OL]. (2017-09-06). http://www.laskerfoundation.org/.
[2] Laplante M, Sabatini D M. mTOR signaling in growth control and disease[J]. Cell, 2012, 149(2):274-293.
[3] Liko D, Hall M N. mTOR in health and in sickness[J]. J Mol Med (Berl), 2015, 93(10):1061-1073.
[4] Heitman J, Movva N R, Hall M N. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast[J]. Science, 1991, 253(5022):905-909.
[5] Kunz J, Henriquez R, Schneider U, et al. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression[J]. Cell, 1993, 73(3):585-596.
[6] Barbet N C, Schneider U, Helliwell S B, et al. TOR controls translation initiation and early G1 progression in yeast[J]. Mol Biol Cell, 1996, 7(1):25-42.
[7] Beck T, Hall M N. The TOR signalling pathway controls nuclear localization of nutrient-regulated transcription factors[J].Nature, 1999, 402(6762):689-692.
[8] Hall M N. TOR and paradigm change:cell growth is controlled[J]. Mol Biol Cell, 2016, 27(18):2804-2806.
[9] Loewith R, Jacinto E, Wullschleger S, et al. Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control[J]. Mol Cell, 2002, 10(3):457-468.
[10] Gonzalez A, Hall M N. Nutrient sensing and TOR signaling in yeast and mammals[J]. EMBO J, 2017, 36(4):397-408.
[11] Vaccarella S, Laversanne M, Ferlay J, et al. Cervical cancer in africa, latin America and the caribbean and asia:regional inequalities and changing trends[J]. Int J Cancer, 2017, 141(10):1997-2001.
[12] Ciesielska U, Nowińska K, Podhorska-Okołów M, et al. The role of human papillomavirus in the malignant transformation of cervix epithelial cells and the importance of vaccination against this virus[J]. Adv Clin Exp Med, 2012, 21(2):235-244.
[13] Kirnbauer R, Booy F, Cheng N, et al. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic[J]. Proc Natl Acad Sci U S A, 1992, 89(24):12180-12184.
[14] Kirnbauer R, Taub J, Greenstone H, et al. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles[J]. J Virol, 1993, 67(12):6929-6936.
[15] Roden R B, Hubbert N L, Kirnbauer R, et al. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition[J]. J Virol, 1996, 70(5):3298-3301.
[16] Harro C D, Pang Y Y, Roden R B, et al. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine[J]. J Natl Cancer Inst, 2001, 93(4):284-292.
[17] Wu T, Hu Y M, Li J, et al. Immunogenicity and safety of an E. coli-produced bivalent human papillomavirus(type 16 and 18) vaccine:A randomized controlled phase 2 clinical trial[J]. Vaccine, 2015, 33(32):3940-3946.
[18] Vesikari T, Brodszki N, van Damme P, et al. A randomized, rouble-blind, phase Ⅲ study of the immunogenicity and Safety of a 9-valent human papillomavirus L1 virus-like particle vaccine (V503) versus gardasil^® in 9-15-Year-Old Girls[J]. Pediatr Infect Dis J, 2015, 34(9):992-998.
[19] De Vincenzo R,Conte C,Ricci C,et al. Long-term efficacy and safety of human papillomavirus vaccination[J]. Int J Womens Health, 2014, 102(6):999-1010.
[20] Crawford N W,Hodgson K, Gold M, et al. Adverse events following HPV immunization in australia:establishment of a clinical network[J]. Hum Vaccin Immunother, 2016, 12(10):2662-2665.
[21] Petrosky E, Bocchini J A Jr, Hariri S, et al. Use of 9-valent human papillomavirus (HPV) vaccine:updated HPV vaccination recommendations of the advisory committee on immunization practices[J]. MMWR Morb Mortal Wkly Rep, 2015, 64(11):300-304.)

2017年拉斯克奖

The 2017 Lasker Awards

PDF

可视化

被引次数

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

本文评价

[1]	宫平, 徐志卿. 光遗传学技术——2021年拉斯克奖基础医学研究奖[J]. 首都医科大学学报, 2021, 42(5): 888-892.
[2]	牛欢, 程杉, 丁卫. 2018年拉斯克奖(Ⅰ)——基础医学研究奖及医学特殊成就奖[J]. 首都医科大学学报, 2018, 39(5): 778-782.
[3]	魏昌伟, 岳云, 吴安石. 2018年拉斯克奖(Ⅱ)[J]. 首都医科大学学报, 2018, 39(5): 783-790.
[4]	李禹正, 张婷, 王晓民. 2016年拉斯克奖[J]. 首都医科大学学报, 2016, 37(5): 703-710.
[5]	张婷, 王晓民. 2014年拉斯克奖[J]. 首都医科大学学报, 2014, 35(5): 533-538.
[6]	罗岚蓉, 李坚. 流产后妇女服用口服避孕药的情况调查[J]. 首都医科大学学报, 2013, 34(5): 746-751.